Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Schellenberg

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
Molecular Pharmacology|May 1, 1985
Inhibition of synaptosomal membrane Na+-Ca2+ exchange transport by amiloride and amiloride analoguesG D Schellenberg, L Anderson, E J Cragoe, et al.
Genetic Epidemiology|January 1, 1993
The Seattle Alzheimer's disease data setE M Wijsman, T D Bird, G M Martin, et al.
Neurobiology of Aging|September 1, 1989
Evidence for etiologic heterogeneity in Alzheimer's diseaseT D Bird, G D Schellenberg, E M Wijsman, et al.
Methods in Enzymology|January 1, 1982
Transketolase from human red blood cellsG D Schellenberg, N M Wilson, B R Copeland, et al.
Nature|September 13, 1990
Alzheimer's disease. Dominant susceptibility genesG M Martin, G D Schellenberg, E M Wijsman, et al.
American Journal of Human Genetics|January 1, 1996
Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sampleG Jarvik, E B Larson, K Goddard, et al.
Neuroreport|May 13, 1999
The tau mutation (val337met) disrupts cytoskeletal networks of microtubulesS Arawaka, M Usami, N Sahara, et al.
Lancet (London, England)|September 18, 1993
Apolipoprotein E genotype and Alzheimer's diseaseH Payami, J Kaye, L L Heston, et al.
Neuroepidemiology|April 15, 1999
The effect of apolipoprotein E epsilon4 in the relationships of smoking and drinking to cognitive functionD Carmelli, G E Swan, T Reed, et al.
Progress in Clinical and Biological Research|January 1, 1992
Genetic heterogeneity, Down syndrome, and Alzheimer diseaseG D Schellenberg, K Kamino, E M Bryant, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Molecular Pharmacology|May 1, 1985
Inhibition of synaptosomal membrane Na+-Ca2+ exchange transport by amiloride and amiloride analoguesG D Schellenberg, L Anderson, E J Cragoe, et al.
Genetic Epidemiology|January 1, 1993
The Seattle Alzheimer's disease data setE M Wijsman, T D Bird, G M Martin, et al.
Neurobiology of Aging|September 1, 1989
Evidence for etiologic heterogeneity in Alzheimer's diseaseT D Bird, G D Schellenberg, E M Wijsman, et al.
Methods in Enzymology|January 1, 1982
Transketolase from human red blood cellsG D Schellenberg, N M Wilson, B R Copeland, et al.
Nature|September 13, 1990
Alzheimer's disease. Dominant susceptibility genesG M Martin, G D Schellenberg, E M Wijsman, et al.
American Journal of Human Genetics|January 1, 1996
Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sampleG Jarvik, E B Larson, K Goddard, et al.
Neuroreport|May 13, 1999
The tau mutation (val337met) disrupts cytoskeletal networks of microtubulesS Arawaka, M Usami, N Sahara, et al.
Lancet (London, England)|September 18, 1993
Apolipoprotein E genotype and Alzheimer's diseaseH Payami, J Kaye, L L Heston, et al.
Neuroepidemiology|April 15, 1999
The effect of apolipoprotein E epsilon4 in the relationships of smoking and drinking to cognitive functionD Carmelli, G E Swan, T Reed, et al.
Progress in Clinical and Biological Research|January 1, 1992
Genetic heterogeneity, Down syndrome, and Alzheimer diseaseG D Schellenberg, K Kamino, E M Bryant, et al.
Pageof 13